Sintx Technologies (SINT) Competitors $2.98 +0.09 (+3.11%) Closing price 04:00 PM EasternExtended Trading$2.96 -0.02 (-0.84%) As of 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SINT vs. NRXS, CODX, DHAI, INBS, ICU, PETV, BTCY, ALUR, BSGM, and SSKNShould you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include NeurAxis (NRXS), Co-Diagnostics (CODX), DIH Holding US (DHAI), Intelligent Bio Solutions (INBS), SeaStar Medical (ICU), PetVivo (PETV), Biotricity (BTCY), Allurion Technologies (ALUR), BioSig Technologies (BSGM), and STRATA Skin Sciences (SSKN). These companies are all part of the "medical equipment" industry. Sintx Technologies vs. NeurAxis Co-Diagnostics DIH Holding US Intelligent Bio Solutions SeaStar Medical PetVivo Biotricity Allurion Technologies BioSig Technologies STRATA Skin Sciences Sintx Technologies (NASDAQ:SINT) and NeurAxis (NASDAQ:NRXS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, community ranking, dividends and analyst recommendations. Which has more volatility and risk, SINT or NRXS? Sintx Technologies has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Comparatively, NeurAxis has a beta of 4.2, suggesting that its share price is 320% more volatile than the S&P 500. Which has preferable earnings and valuation, SINT or NRXS? Sintx Technologies has higher earnings, but lower revenue than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSintx Technologies$1.25M3.20-$8.26M-$50.56-0.06NeurAxis$2.69M5.74-$14.63M-$1.20-1.79 Is SINT or NRXS more profitable? Sintx Technologies has a net margin of -358.79% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Sintx Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Sintx Technologies-358.79% -140.68% -78.29% NeurAxis -492.76%N/A -641.25% Does the MarketBeat Community favor SINT or NRXS? Sintx Technologies received 35 more outperform votes than NeurAxis when rated by MarketBeat users. However, 100.00% of users gave NeurAxis an outperform vote while only 61.02% of users gave Sintx Technologies an outperform vote. CompanyUnderperformOutperformSintx TechnologiesOutperform Votes3661.02% Underperform Votes2338.98% NeurAxisOutperform Votes1100.00% Underperform VotesNo Votes Does the media prefer SINT or NRXS? In the previous week, NeurAxis had 1 more articles in the media than Sintx Technologies. MarketBeat recorded 7 mentions for NeurAxis and 6 mentions for Sintx Technologies. NeurAxis' average media sentiment score of 1.03 beat Sintx Technologies' score of 0.40 indicating that NeurAxis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sintx Technologies 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NeurAxis 4 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals have more ownership in SINT or NRXS? 18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 11.8% of NeurAxis shares are held by institutional investors. 0.0% of Sintx Technologies shares are held by company insiders. Comparatively, 15.2% of NeurAxis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryNeurAxis beats Sintx Technologies on 9 of the 15 factors compared between the two stocks. Remove Ads Get Sintx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SINT vs. The Competition Export to ExcelMetricSintx TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.99M$4.44B$5.67B$8.29BDividend YieldN/A32.62%4.55%4.02%P/E Ratio-0.0628.8524.5919.28Price / Sales3.2050.38395.1794.03Price / CashN/A51.0838.1634.64Price / Book0.016.267.054.46Net Income-$8.26M$67.64M$3.20B$247.07M7 Day Performance3.13%9.97%1.46%3.05%1 Month Performance-45.50%-1.00%5.76%-2.87%1 Year Performance-70.30%25.31%14.94%4.53% Sintx Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SINTSintx Technologies0.2765 of 5 stars$2.98+3.1%N/A-84.4%$4.00M$1.25M-0.0640NRXSNeurAxisN/A$2.21+2.5%N/A-39.0%$15.89M$2.46M-1.2019Positive NewsGap DownCODXCo-Diagnostics4.2396 of 5 stars$0.45-6.7%$1.50+231.9%-60.7%$14.43M$7.32M-0.33100Upcoming EarningsNews CoverageGap DownHigh Trading VolumeDHAIDIH Holding US0.2148 of 5 stars$0.30-1.2%N/A-69.8%$14.30M$64.47M-1.01N/AGap UpHigh Trading VolumeINBSIntelligent Bio Solutions0.2778 of 5 stars$2.10-0.9%N/A-45.5%$14.24M$3.03M0.0010News CoverageGap UpICUSeaStar Medical0.1837 of 5 stars$2.17+6.9%N/A-89.1%$14.04M$68,000.00-0.192Upcoming EarningsNews CoveragePETVPetVivoN/A$0.55+0.1%N/A-50.9%$12.96M$1.05M-1.2220Gap DownBTCYBiotricityN/A$0.50-0.2%N/A-68.8%$12.46M$12.06M-0.4640Gap DownALURAllurion Technologies3.1256 of 5 stars$2.58+8.4%$54.17+2,000.3%-92.6%$12.36M$34.75M-0.21501Upcoming EarningsGap DownBSGMBioSig Technologies1.2981 of 5 stars$0.68+11.5%$2.75+302.0%-8.4%$11.79M$39,000.000.0050Positive NewsGap UpSSKNSTRATA Skin Sciences2.9756 of 5 stars$2.63-5.4%$6.00+128.1%-48.4%$10.97M$32.68M-0.99120Upcoming EarningsNews Coverage Remove Ads Related Companies and Tools Related Companies NRXS Alternatives CODX Alternatives DHAI Alternatives INBS Alternatives ICU Alternatives PETV Alternatives BTCY Alternatives ALUR Alternatives BSGM Alternatives SSKN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SINT) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sintx Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sintx Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SINT Stock Free SINT Stock Alerts